Key Insights

Highlights

Treatment Research

1 treatments under study, led by Ald101

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00654433Phase 3Terminated

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

Showing all 1 trials

Research Network

Common Treatments

  • Ald1011

Active Sponsors

  • Aldagen1

Top Investigators

Related Conditions

  • Mucopolysaccharidosis1
  • Inherited Metabolic Diseases1
  • Inborn Errors Of Metabolism1
  • Lysosomal Storage Disorders1

Activity Timeline